Improving the stability of proteins for better pharmaceuticals
EmCAST: Stabilizing Proteins and Tuning Dynamics with High Precision and Accuracy
This study is working on a new tool called EmCAST that helps make proteins more stable, which is really important for improving the safety and effectiveness of protein-based medicines, and they’ll be testing it on different protein structures to see how well it works.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Montana NIH-funded |
| Lab location | 1 site (Missoula, United States) |
| Project ID | NIH-10896344 on NIH RePORTER |
What this research studies
This research focuses on developing a new tool called EmCAST that aims to stabilize proteins with high precision and accuracy. By utilizing advanced algorithms and empirical data from protein structures, the project seeks to reduce the errors in predicting how mutations affect protein stability. This is crucial for enhancing the effectiveness and safety of protein-based medications, which rely on stable proteins for their shelf-life and immunogenicity. The researchers will test EmCAST on various protein structures to demonstrate its broad applicability in stabilizing proteins.
Who could benefit from this research
Good fit: Patients who rely on protein-based medications, such as those with certain autoimmune diseases or genetic disorders, would benefit from this research.
Not a fit: Patients who are not using protein-based therapies or those with conditions that do not involve protein stability issues may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and safer protein-based pharmaceuticals.
How similar studies have performed: Other research has shown promise in stabilizing proteins using computational methods, but EmCAST represents a novel approach with the potential for significant improvements.
Where this research is happening
Missoula, United States
- University of Montana — Missoula, United States (Active)
Researchers
- Principal investigator: Bowler, Bruce E — University of Montana
- Study coordinator: Bowler, Bruce E
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.